Study number 8543-937
Dates
Feb 16 2025-Feb 24 2025
Location
Daytona Beach, Florida
Age
18-75
Gender
Male/Female
Compensation
$3,127
Group
A3a OR A3b
This is a research study for an investigational drug being developed for the treatment of symptomatic neurogenic orthostatic hypotension (a condition that causes a drop in blood pressure when standing up or changing positions) associated with a group of diseases that destroy the nervous system over time (synucleinopathies), and Alzheimer’s disease (a brain disorder that causes a gradual decline in memory, thinking, and the ability to perform daily tasks).
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Adults, age 18-75
- Body Mass Index between 18-32
- Study involves 1 stay of 4 nights & 1 follow up visit
- Compensation up to $3,127 may be provided for time and participation
- Refer a friend to receive $350 per qualified referral
Call Now to Schedule Your Screening Appointment!
A3a:
Check-in: Feb 16
Check-out: Feb 20
Follow up Visit: Feb 24
OR
A3b:
Check-in: Feb 17
Check-out: Feb 21
Follow up Visit: Feb 25